- Investing Ideas
- /
- Swedish Fast Growing Stocks With High Insider Ownership
Swedish Fast Growing Stocks With High Insider Ownership
Results
91
0 new
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
91 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.44 | 0.6% | 8.9% | SEK 389.9m | SEK 2.20 | PS3.4x | E86.1% | n/a | Tech | ||
CALTX | SEK 207.00 | 0.2% | 115.8% | SEK 11.2b | SEK 227.50 | PS7x | E51.9% | n/a | Pharmaceuticals & Biotech | ||
YUBICO | SEK 319.50 | 7.2% | 221.4% | SEK 27.5b | SEK 295.00 | PE142x | E43.7% | n/a | Software | ||
TRUE B | SEK 35.48 | -0.7% | 4.0% | SEK 12.2b | SEK 57.20 | PE25.6x | E21.6% | 1.1% | Software | ||
MAGLE | SEK 38.20 | 1.1% | 26.5% | SEK 412.6m | SEK 50.00 | PE53.6x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
CTT | SEK 280.00 | -3.1% | 25.0% | SEK 3.5b | n/a | PE34.4x | E24.8% | 1.9% | Capital Goods | ||
FNOX | SEK 58.54 | 4.1% | 3.6% | SEK 35.7b | SEK 77.88 | PE54.9x | E22.6% | 0.3% | Software | ||
BIOA B | SEK 165.80 | 8.5% | -48.4% | SEK 14.6b | SEK 320.40 | PS58.1x | E102.8% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.69 | -3.4% | -68.6% | SEK 225.7m | SEK 7.90 | PS30.9x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.19 | -4.8% | -23.2% | SEK 236.9m | SEK 2.84 | PS2.2x | E115.5% | n/a | Tech | ||
ORGC | SEK 3.16 | 1.6% | -23.3% | SEK 310.1m | SEK 3.00 | PS2.2x | E109.0% | n/a | Materials | ||
CRAD B | SEK 43.20 | -1.8% | 39.1% | SEK 1.5b | SEK 57.00 | PE27.1x | E33.9% | n/a | Healthcare | ||
FLEXQ | SEK 11.50 | -2.1% | -36.5% | SEK 154.1m | SEK 25.00 | PS1.4x | E118.7% | n/a | Capital Goods | ||
ESGR B | SEK 30.30 | 1.7% | -58.2% | SEK 199.6m | SEK 58.00 | PS1.1x | E57.0% | n/a | Household | ||
CTM | SEK 7.34 | 9.7% | -57.4% | SEK 555.3m | SEK 29.70 | PB0.3x | E123.9% | 0% | Media | ||
KLAR | SEK 0.47 | -7.9% | -15.6% | SEK 60.5m | SEK 1.00 | PB2.9x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
SENZA | SEK 7.50 | 5.6% | -13.6% | SEK 221.3m | SEK 16.00 | PS4x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
4C | SEK 18.30 | -3.2% | -27.8% | SEK 642.9m | SEK 22.00 | PS2.2x | E108.0% | n/a | Software | ||
EQT | SEK 344.80 | 2.4% | 63.3% | SEK 407.5b | SEK 361.36 | PE118.7x | E56.8% | 1.0% | Diversified Financials | ||
MIDS | SEK 1.21 | -4.1% | -38.8% | SEK 252.9m | SEK 2.80 | PS3.9x | E89.9% | n/a | Semiconductors | ||
NIUTEC | SEK 6.18 | 1.6% | -16.5% | SEK 125.9m | SEK 9.50 | PB1.1x | E101.6% | n/a | Capital Goods | ||
EGTX | SEK 5.80 | 12.0% | 38.4% | SEK 1.7b | SEK 11.40 | PS24x | E90.0% | n/a | Pharmaceuticals & Biotech | ||
GIAB | SEK 0.75 | 4.9% | -65.3% | SEK 11.8m | SEK 1.71 | PE-1x | E72.9% | n/a | Commercial Services | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods |